Does TAMOXIFEN Cause Injection site extravasation? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Injection site extravasation have been filed in association with TAMOXIFEN (Tamoxifen Citrate). This represents 0.3% of all adverse event reports for TAMOXIFEN.
31
Reports of Injection site extravasation with TAMOXIFEN
0.3%
of all TAMOXIFEN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site extravasation From TAMOXIFEN?
Of the 31 reports, 1 (3.2%) required hospitalization, and 1 (3.2%) were considered life-threatening.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMOXIFEN. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does TAMOXIFEN Cause?
Malignant neoplasm progression (1,499)
Metastases to bone (894)
Fatigue (729)
Nausea (611)
Metastases to liver (595)
Breast cancer (584)
Disease progression (571)
Breast cancer metastatic (515)
Diarrhoea (512)
Arthralgia (497)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which TAMOXIFEN Alternatives Have Lower Injection site extravasation Risk?
TAMOXIFEN vs TAMSULOSIN
TAMOXIFEN vs TAPENTADOL
TAMOXIFEN vs TAPINAROF
TAMOXIFEN vs TARCEVA
TAMOXIFEN vs TARLATAMAB